Insider Transactions in Q1 2024 at Akoya Biosciences, Inc. (AKYA)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 23
2024
|
Niro Ph.D Ramachandran Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,006
-0.96%
|
$8,024
$4.79 P/Share
|
Mar 23
2024
|
Frederic Pla Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,006
-1.94%
|
$8,024
$4.79 P/Share
|
Mar 23
2024
|
Brian Mc Kelligon President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,135
-3.08%
|
$28,540
$4.79 P/Share
|
Mar 20
2024
|
Brian Mc Kelligon President and CEO |
SELL
Open market or private sale
|
Direct |
7,500
-3.13%
|
$30,000
$4.97 P/Share
|
Mar 20
2024
|
Brian Mc Kelligon President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+3.04%
|
$0
$0.3 P/Share
|
Mar 13
2024
|
Robert G Shepler Director |
BUY
Bona fide gift
|
Indirect |
369,592
+50.0%
|
-
|
Mar 13
2024
|
Robert G Shepler Director |
SELL
Bona fide gift
|
Indirect |
369,592
-100.0%
|
-
|
Mar 13
2024
|
Brian Mc Kelligon President and CEO |
SELL
Open market or private sale
|
Direct |
7,500
-3.23%
|
$30,000
$4.94 P/Share
|
Mar 01
2024
|
Niro Ph.D Ramachandran Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,305
-1.09%
|
$13,830
$6.03 P/Share
|
Mar 01
2024
|
Frederic Pla Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,049
-1.94%
|
$12,294
$6.03 P/Share
|
Mar 01
2024
|
Jennifer Kamocsay General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,283
-3.2%
|
$19,698
$6.03 P/Share
|
Mar 01
2024
|
Brian Mc Kelligon President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,244
-2.68%
|
$61,464
$6.03 P/Share
|
Feb 22
2024
|
John Frederick Ek CFO |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+15.22%
|
-
|
Feb 22
2024
|
Niro Ph.D Ramachandran Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+14.16%
|
-
|
Feb 22
2024
|
Frederic Pla Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+24.9%
|
-
|
Feb 22
2024
|
Jennifer Kamocsay General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+25.45%
|
-
|
Feb 22
2024
|
Brian Mc Kelligon President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
87,500
+26.71%
|
-
|